Jolinta Y Lin
Overview
    Explore the profile of Jolinta Y Lin including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              16
            
            
              Citations
              87
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Bai J, Gong C, Hu Y, Bruner D, Torres M, Buchwald Z, et al.
  
  
    Int J Radiat Oncol Biol Phys
    . 2025 Mar;
    
    PMID: 40058710
  
  
          Purpose: Up to 95% of women during and after radiation therapy (RT) for breast cancer have reported cutaneous toxicity. However, the biologic link between skin microbiome and skin toxicities from...
      
2.
        
    
    Lin J, Remick J, Singh V
  
  
    JAMA Oncol
    . 2024 Apr;
          10(6):698-699.
    
    PMID: 38602664
  
  
          No abstract available.
      
3.
        
    
    Ali N, Dhere T, Bates J, Lorenz J, Janopaul-Naylor J, Schlafstein A, et al.
  
  
    Pract Radiat Oncol
    . 2023 Oct;
          14(1):e1-e8.
    
    PMID: 37802397
  
  
          Purpose: Early exposure to oncology care during the preclinical years of medical school may translate to increased student interest in oncology-related fields and improved understanding of oncologic treatment modalities, including...
      
4.
        
    
    Pfister N, Cao Y, Schlafstein A, Switchenko J, Patel P, McDonald M, et al.
  
  
    Adv Radiat Oncol
    . 2023 Feb;
          8(2):101155.
    
    PMID: 36845623
  
  
          Purpose: Anal cancer affects a disproportionate percentage of persons infected with human immunodeficiency virus (HIV). We analyzed a cohort of patients with HIV and anal cancer who received modern radiation...
      
5.
        
    
    Zhou B, Wang J, Yang X, Henry S, Lin J, Torres M, et al.
  
  
    Ultrasound Med Biol
    . 2022 Nov;
          49(1):309-317.
    
    PMID: 36441032
  
  
          Accurate assessment of radiation-induced breast toxicity is crucial for the management of breast radiation therapy (RT). Standard assessment of breast toxicity based on clinicians' visual inspection and palpation has considerable...
      
6.
        
    
    Janopaul-Naylor J, Roberts S, Shu H, Kesarwala A, Lin J, Switchenko J, et al.
  
  
    JAMA Netw Open
    . 2022 Jan;
          5(1):e2142720.
    
    PMID: 35015068
  
  
          No abstract available.
      
7.
        
    
    Escott C, Zaenger D, Switchencko J, Lin J, Abugideiri M, Arciero C, et al.
  
  
    Clin Breast Cancer
    . 2020 Jul;
          20(6):e701-e710.
    
    PMID: 32665190
  
  
          Background: Two large randomized trials, CALGB 9343 and PRIME II, support omission of radiotherapy after breast conserving surgery (BCS) in elderly women with favorable-risk early stage breast cancer intending to...
      
8.
        
    
    Lin J, Yang X, Serra M, Miller A, Godette K, Kahn S, et al.
  
  
    J Surg Oncol
    . 2019 Nov;
          120(8):1397-1403.
    
    PMID: 31705561
  
  
          Background: We previously reported a prospective study showing axillary lymph node dissection (ALND) is associated with increased breast skin thickening during and 6 weeks post-radiation therapy (RT), and now report...
      
9.
        
    
    Duininck G, Lopez-Aguiar A, Lee R, Miller L, Dariushnia S, Wu C, et al.
  
  
    J Surg Oncol
    . 2019 Oct;
          120(8):1365-1370.
    
    PMID: 31642056
  
  
          Background: Hepatitis C (HCV) is the primary etiology of hepatocellular carcinoma (HCC) in the US multidisciplinary disease management teams (DMT) that optimize oncologic care. The impact of DMT for HCC...
      
10.
        
    
    Tian S, Jiang R, Madden N, Ferris M, Buchwald Z, Xu K, et al.
  
  
    Cancer
    . 2019 Sep;
          126(1):37-45.
    
    PMID: 31532544
  
  
          Background: Perioperative chemotherapy (POC) is one standard approach for the treatment of resectable cancers of the stomach and gastroesophageal junction (GEJ), whereas there has been growing interest in preoperative therapies....